Our Partnerships

Bringing new oncology medicines to patients requires teamwork. 

We’re interested in establishing strategic partnerships with pharma and other biotech companies to develop transformative medicines.

We are disrupting the drug discovery process, working with partners to accelerate discovery and development, reduce attrition rates and save costs in a climate where R&D expenditure continues to climb.

The MOSAIC platform adds value throughout the drug discovery life cycle, from tumour agnostic target identification to the understanding mechanisms of resistance to existing drugs. 

For over a decade, our team has been working with commercial partners to develop transformative new technologies and capabilities to uncover promising new drug targets that would allow for more medicines to be taken directly to patients. 

Get in touch if you are interested in exploring ways that we can work together: partnerships@mosaic-tx.com

Join Our Team